Sign Up For Life Science Leader Magazine

THE CURRENT ISSUE

  • Defining Presence As A Leadership Behavior
    Defining Presence As A Leadership Behavior

    In my writings, I define leadership presence as the “right stuff of leadership,” and, by doing so, I embrace a holistic concept. For me, presence is more surface appeal — as the term executive presence connotes; it denotes a leader’s approach to getting the most out of themselves as well as their team. By that definition of presence encompasses conviction, authority, power, and the application of them through a leader’s actions and words.

  • Global Drug Discovery Outsourcing Market Gaining Momentum
    Global Drug Discovery Outsourcing Market Gaining Momentum

    There is no doubt that global pharmaceutical companies have a desperate need to develop better drugs with high success rates. Consequently, more drug companies are utilizing external resources, while still constantly streamlining their internal R&D systems.

  • eTMFs: Moving From Electronic Filing Cabinet To Strategic Asset
    eTMFs: Moving From Electronic Filing Cabinet To Strategic Asset

    In 2010, McKinsey & Company published a report on the need to reinvent drug development through technologies designed to streamline the clinical trials process. The report recommends implementing technologies that represent a “clean-sheet” or redesigned traditional clinical trial methodology.

  • Merck’s Continuous Process Improvement
    Merck’s Continuous Process Improvement

    Continuous improvement doesn’t just depend upon Lean principles and/or zero-based budgeting. It depends upon people inspired by a culture that values learning, promotes problem-solving skills, and strives toward big goals by making small improvements every day.

  • The Falsified Medicines Directive – What Does It Really Mean?
    The Falsified Medicines Directive – What Does It Really Mean?

    The trade in falsified medicines — medicines that look real but really aren’t what they seem — is a huge and growing one, and it is putting patients’ health and even their lives at risk. Along with regulatory authorities around the world, the European Union is putting directives into place that could begin to slow this deadly trade.

  • Don’t Let Big Data Analytics Prevent You From Being Brilliant At The Basics
    Don’t Let Big Data Analytics Prevent You From Being Brilliant At The Basics

    Most of those in our industry are only viewing the tip of the iceberg when it comes to looking at how to use Big Data — ignoring the massive amounts residing below the water’s surface. When I think of the potential Big Data presents for the field of life sciences, it reminds me of The Rime of the Ancient Mariner — “Water, water, everywhere, nor any drop to drink.”

  • New Medicare Data And Litigation Provide Fresh Reasons For Congress To Reform 340B
    New Medicare Data And Litigation Provide Fresh Reasons For Congress To Reform 340B

    Medicare continues to release unfiltered information on provider utilization, which gives some illuminating information, particularly when that data is cross-walked to other sources. A case in point is the publication of the top Medicare hospital billers in the country: 21 of the top 25 are 340B hospitals and therefore access the substantial pharmaceutical discounts under that program.

More Magazine Articles....

LIFE SCIENCE TRAINING INSTITUTE

More From LSTI

 UPCOMING EVENTS

Building An Effective GMP Training System: A Risk-Based Approach

July 30, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Improving Biological Facility Design: Critical Tips for Compliance

August 6, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Serialization Preparedness – What you Must Know for Bullet-Proof Programs

August 12, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate

Device Compliance Audit Management - Best Practices to Meet Global Regulations and Notified Body Expectations

August 13, 2014
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate
See All Events

LIFE SCIENCE SUPPLEMENTS

 

2014 CMO Pharma Development & Manufacturing

Life Science Leader’s readership of pharmaceutical and biopharmaceutical executives have told us about their struggles in efficiently vetting potential CMO and CRO partners. In response to this input, Life Science Leader developed the Leadership Awards based on the industry leading research conducted by Nice Insight.

2014 CRO Leadership Awards 2013 CMO Leadership Awards
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers

VIEW THE DIGITAL EDITION